Register
Login:
Share:
Email Facebook Twitter

Be a contrarian investor says Ranjeet Singh Watch here

Be a contrarian investor says Ranjeet Singh


Provexis Share Price (PXS)



Share Price Information for Provexis (PXS)


Share Price: 0.5495Bid: 0.50Ask: 0.599Change: 0.00 (0.00%)No Movement on Provexis
Spread: 0.099Spread as %: 19.80%Open: 0.5495High: 0.5495Low: 0.5495Yesterday’s Close: 0.5495

Provexis Plc Ord 0.1P

Provexis is listed in the FTSE AIM All-Share
Provexis is part of the Food Products sector






Share Price SpacerPrice
0.5495

Share Price SpacerBid
0.50

Share Price SpacerAsk
0.599

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
430,910

Share Price SpacerOpen
0.5495

Share Price SpacerHigh
0.5495

Share Price SpacerLow
0.5495

Share Price SpacerClose
0.5495

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 1,750.82m £9.62m 300,000

52 Week High 1.25 52 Week High Date 28-NOV-2016
52 Week Low 0.23 52 Week Low Date 9-JUN-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
2 10,000 420,910 -18.317 -0.03 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

21-Apr-17
15:51:32
0.5348
10,000
Sell* 
0.50
0.599
53.48
Trade Type:
Ordinary

21-Apr-17
12:10:06
0.5501
420,910
Buy* 
0.50
0.599
2,315
Trade Type:
Ordinary

19-Apr-17
13:16:33
0.5739
16,737
Buy* 
0.50
0.599
96.05
Trade Type:
Ordinary




View more Provexis trades >>

Directors Deals for Provexis (PXS)
Trade DateActionNotifierPriceCurrencyAmountHolding
15-Sep-16Placing
Trade Notifier Information for Provexis
Dawson Buck held the position of Non-Executive Chairman at Provexis at the time of this trade.
 Dawson Buck
0.24GBX10,416,66725416667
07-Jan-16Buy
Trade Notifier Information for Provexis
Ian Ford held the position of Finance Director at Provexis at the time of this trade.
 Ian Ford
0.29GBX2,798,1685000000
06-Jan-16Buy
Trade Notifier Information for Provexis
Dawson Buck held the position of Non-Executive Chairman at Provexis at the time of this trade.
 Dawson Buck
0.27GBX2,093,56715000000
View more Provexis directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Today 13:57gixerRE: bloodflow health pill EFSA Approved0.5495No Opinion
We have a good head start in China as well as our man at By-Health is well up on Fruitflow.
He did work for us :-)

Xuguang Zhang
Director, Science and Technology Centre; Director, Nutrition and Health Research Centre
Company NameBy-Health Co., Ltd

Past
Senior Research Scientist/Project Manager
Company NamePROVEXIS PLC

https://www.linkedin.com/in/xuguang-zhang-a7ab8062/
Today 13:35KHammerRE: bloodflow health pill EFSA Approved0.5495Hold
Dont read iii so missed your posts there, thanks for adding post here.

I dont think it matters that much if they work differently if they have similar effect/outcome.

We do seem to have a big head start and dsm pushing fruitflow, but even so we now have a competitor with EFSA approval.

Will hold for now in any case as already down and will be interesting to see what happens in China over next few years.
Today 11:33gixerRE: bloodflow health pill EFSA Approved0.5495No Opinion
This is what i wrote when someone found it on iii last month

"Barry Callebaut got efsa approval on cocoa flavanols back in June 2012.

http://www.barry-callebaut.com/news/2012/07/efsa-issues-positive-scientific-opinion-barry-callebaut%E2%80%99s-health-claim-cocoa-flavanols

and then extended it in 2015

http://www.barry-callebaut.com/news/2015/04/european-commission-extends-barry-callebaut%E2%80%99s-health-claim-acticoa%C2%AE-products-extracts

Naturex then signed a deal with… Read More
Today 09:58KHammerRE: bloodflow health pill EFSA Approved0.5495Hold
Today 09:57KHammerbloodflow health pill EFSA Approved0.5495Hold
https://www.pressreader.com/uk/daily-mail/20170323/282724816754669

Ouch. Lets hope China doesnt hear about this one...

Not sure if its been posted before but read about it in today's Mail on Sunday....
Wed 16:06pickledonionRE: Pxs0.5495No Opinion
Yes, early investment is key. Although I think I was 7-8 years early on my initial buy haha!
I only sold recently as the spikes were too good an opportunity to not take profit (for me). They generally follow positive news that when not backed up by an increase in revenue, tail off rather rapidly.
I'm also very interested in how things pan out in China, but with the By-Health collaboration at such an early stage, I'll risk being out for the potential benefit of a lower buy in price. Obviously… Read More

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Provexis (PXS) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.